Companies: 10,795·Total market cap: $144.5T
Compass Therapeutics, Inc.

Compass Therapeutics, Inc.

CMPXNASDAQHealthcare● Active
$2.02
$-0.02(-0.98%)
Market Cap$279338328
P/E Ratio
52W High$6.88
52W Low$1.61
Overview

Compass Therapeutics, Inc. (CMPX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CMPX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.43cmpx eps ttm · cmpx earnings per shareEarnings history
PE Ratio (TTM)cmpx pe ratio ttm · cmpx price to earningsPE Ratio deep dive
Revenue (TTM)0.00cmpx revenue ttm · cmpx annual revenueFull revenue history
Dividend YieldNo Dividenddoes cmpx pay dividends · cmpx dividend yieldDividend history
Shares Outstanding157.7Mcmpx shares outstanding · cmpx floatShares outstanding history
Next EarningsAug 10, 2026Est.cmpx earnings date · cmpx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00▼ 100.00% YoY
202320242025
compass therapeutics, inc. revenue · cmpx revenue 2025
FY 2025Net Income-$66.5M▼ 34.66% YoY
202320242025
compass therapeutics, inc. net income · cmpx profit 2025
FY 2025EPS$-0.42▼ 16.67% YoY
202320242025
cmpx eps · compass therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$68.2MEPS: $-0.43View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy15 analystsis cmpx a buy · cmpx analyst rating
Strong Buy
0
Buy
15
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$6.00Low
$2.02Current
$10.40Avg Target414.85% upside
$15.00High
cmpx price target · cmpx 12 month forecast

Total: 15 · Buy rate: 100.0%

The CMPX analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $10.40, representing +414.85% upside from the current price of $2.02.

Stock Performance

Full History
1D-0.98%
1W-2.88%
1M+10.38%
3M-63.34%
YTD-62.38%
1Y-21.40%
5Y-63.27%

About Compass Therapeutics, Inc.

CEOThomas J. Schuetz
IPO DateApr 5, 2021
Employees35
CountryUS

Compass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials. The company's work involves creating a…

what is compass therapeutics, inc. · cmpx stock overview · compass therapeutics, inc. company profile · who is compass therapeutics, inc. ceo · cmpx NASDAQ · compass therapeutics, inc. headquarters · compass therapeutics, inc. business segments

About Stock Overview & Key Data

Compass Therapeutics, Inc. (CMPX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 5, 2021. As of the latest trading session, CMPX stock price is $2.02, with a market capitalization of $279.3M. The stock has returned -21.40% over the past 12 months and -62.38% year-to-date.

According to 15 Wall Street analysts, the consensus rating for Compass Therapeutics, Inc. stock is Buy, with an average 12-month price target of $10.40. In fiscal year 2025, Compass Therapeutics, Inc. reported revenue of — and net income of -$66.5M. For detailed data — including Compass Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Compass Therapeutics, Inc. (CMPX) stock price is $2.02. The stock is traded on NASDAQ under the ticker symbol CMPX. The 52-week range is $1.61 – $6.88.

CMPX stock priceCMPX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice